EGFR and neoplasm: For instance, Koojimans et al. transfected producer cells with the Ega1 nanobody (a competitive ligand for EGFR) fused C-terminal to a GPI signal peptide, yielding EVs capable of blocking EGFR signaling in recipient HeLa and A431 tumor cells [99].